136 related articles for article (PubMed ID: 38666383)
1. Prime Time for a Trial Assessing Safety of Intravenous Thrombolysis in Patients Treated With Direct Oral Anticoagulants.
Boehme C; Mayer-Suess L; Mikšová D; Lang W; Knoflach M; Kiechl S;
Stroke; 2024 Jun; 55(6):e149-e150. PubMed ID: 38666383
[No Abstract] [Full Text] [Related]
2. Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated With Non-Vitamin K Antagonist Oral Anticoagulants: An Editorial Review.
Tsivgoulis G; Safouris A
Stroke; 2017 Jul; 48(7):2031-2033. PubMed ID: 28536167
[No Abstract] [Full Text] [Related]
3. Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update.
Derex L; Paris C; Nighoghossian N
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331961
[No Abstract] [Full Text] [Related]
4. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
[TBL] [Abstract][Full Text] [Related]
5. Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use.
Neal AJ; Campbell BC; Chandratheva A; Hand PJ; Davis SM
J Clin Neurosci; 2014 Nov; 21(11):2013-5. PubMed ID: 24984844
[TBL] [Abstract][Full Text] [Related]
6. Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis.
Wong JWP; Churilov L; Dowling R; Mitchell P; Bush S; Kanesan L; Yan B
Cerebrovasc Dis; 2018; 46(5-6):193-199. PubMed ID: 30384367
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta-Analysis.
Ghannam M; AlMajali M; Galecio-Castillo M; Al Qudah A; Khasiyev F; Dibas M; Ghazaleh D; Vivanco-Suarez J; Morán-Mariños C; Farooqui M; Rodriguez-Calienes A; Koul P; Roeder H; Shim H; Samaniego E; Leira EC; Adams HP; Ortega-Gutierrez S
J Am Heart Assoc; 2023 Dec; 12(24):e031669. PubMed ID: 38108256
[TBL] [Abstract][Full Text] [Related]
8. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
[TBL] [Abstract][Full Text] [Related]
9. Safety of Recanalization Therapy in Patients with Acute Ischemic Stroke Under Anticoagulation: A Systematic Review and Meta-Analysis.
Liu M; Zheng Y; Li G
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2296-2305. PubMed ID: 30017747
[TBL] [Abstract][Full Text] [Related]
10. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
[TBL] [Abstract][Full Text] [Related]
11. Review of the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study): How Low Can We Go With Intravenous Tissue-Type Plasminogen Activator Dose and Blood Pressure Level?
Strbian D; Saposnik G
Stroke; 2016 Dec; 47(12):3063-3064. PubMed ID: 27789665
[No Abstract] [Full Text] [Related]
12. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
[TBL] [Abstract][Full Text] [Related]
14. Risks and benefits of early antithrombotic therapy after thrombolytic treatment in patients with acute stroke.
Amaro S; Llull L; Urra X; Obach V; Cervera Á; Chamorro Á
PLoS One; 2013; 8(8):e71132. PubMed ID: 23951093
[TBL] [Abstract][Full Text] [Related]
15. Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
Kam W; Holmes DN; Hernandez AF; Saver JL; Fonarow GC; Smith EE; Bhatt DL; Schwamm LH; Reeves MJ; Matsouaka RA; Khan YM; Unverdorben M; Birmingham MC; Lyden PD; Asimos AW; Altschul D; Schoonover TL; Jumaa MA; Nomura JT; Suri MFK; Moore SA; Lafranchise EF; Olson D; Peterson ED; Xian Y
JAMA; 2022 Feb; 327(8):760-771. PubMed ID: 35143601
[TBL] [Abstract][Full Text] [Related]
16. Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm.
Shono Y; Sugimori H; Matsuo R; Fukushima Y; Wakisaka Y; Kuroda J; Ago T; Kamouchi M; Kitazono T
Int J Stroke; 2018 Oct; 13(7):734-742. PubMed ID: 29543141
[TBL] [Abstract][Full Text] [Related]
17. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants.
Okada T; Yoshimoto T; Wada S; Yoshimura S; Chiba T; Egashira S; Kimura S; Shiozawa M; Inoue M; Ihara M; Toyoda K; Takashima H; Koga M
J Am Heart Assoc; 2022 Oct; 11(19):e025809. PubMed ID: 36129032
[TBL] [Abstract][Full Text] [Related]
19. Successful intravenous thrombolysis in acute ischaemic stroke in a patient on rivaroxaban treatment.
Kawiorski MM; Alonso-Canovas A; de Felipe Mimbrera A; Sainz de la Maza S; Alvarez-Velasco R; Zarza B; Masjuan J
Thromb Haemost; 2014 Mar; 111(3):557-8. PubMed ID: 24196421
[No Abstract] [Full Text] [Related]
20. To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours.
Kam W; Xian Y
J Am Heart Assoc; 2022 Oct; 11(19):e027238. PubMed ID: 36129053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
